View Filing Data

Document and Entity Information - USD ($)	3 Months Ended
Document and Entity Information - USD ($)	Mar. 31, 2011	May 09, 2011	Jun. 30, 2009
Document and Entity Information [Abstract]
Entity Registrant Name	MEDICAL PROPERTIES TRUST INC
Entity Central Index Key	0001287865
Document Type	10-Q
Document Period End Date	Mar. 31, 2011
Amendment Flag	false
Document Fiscal Year Focus	2011
Document Fiscal Period Focus	Q1
Current Fiscal Year End Date	--12-31
Entity Well-known Seasoned Issuer	Yes
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Filer Category	Large Accelerated Filer
Entity Public Float			$ 0
Entity Common Stock, Shares Outstanding		111,715,603

Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Mar. 31, 2011	Dec. 31, 2010
Real estate assets
Land, buildings and improvements, and intangible lease assets	$ 1,223,512	$ 1,032,369
Mortgage loans	165,000	165,000
Gross investment in real estate assets	1,388,512	1,197,369
Accumulated depreciation and amortization	(83,988)	(76,094)
Net investment in real estate assets	1,304,524	1,121,275
Cash and cash equivalents	7,010	98,408
Interest and rent receivable	26,978	26,176
Straight-line rent receivable	30,675	28,912
Other loans	55,868	50,985
Other assets	24,033	23,058
Total Assets	1,449,088	1,348,814
Liabilities
Debt, net	476,354	369,970
Accounts payable and accrued expenses	37,818	35,974
Deferred revenue	20,877	23,137
Lease deposits and other obligations to tenants	23,768	20,157
Total liabilities	558,817	449,238
Equity
Preferred stock, $0.001 par value. Authorized 10,000 shares; no shares outstanding	0	0
Common stock, $0.001 par value. Authorized 150,000 shares; issued and outstanding - 110,405 shares at March 31, 2011, and 110,225 shares at December 31, 2010	110	110
Additional paid in capital	1,053,590	1,051,785
Distributions in excess of net income	(160,154)	(148,530)
Accumulated other comprehensive loss	(3,124)	(3,641)
Treasury shares, at cost	(262)	(262)
Total Medical Properties Trust, Inc. stockholders' equity	890,160	899,462
Non-controlling interests	111	114
Total equity	890,271	899,576
Total Liabilities and Equity	$ 1,449,088	$ 1,348,814

Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - $ / shares	Mar. 31, 2011	Dec. 31, 2010
Equity
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares authorized	10,000	10,000
Preferred stock, shares outstanding	0	0
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	150,000	150,000
Common stock, shares issued	110,405	110,225
Common stock, shares outstanding	110,405	110,225

Condensed Consolidated Statements of Operations (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2011	Mar. 31, 2010
Revenues
Rent billed	$ 28,673	$ 21,248
Straight-line rent	1,735	1,811
Interest and fee income	5,291	7,799
Total revenues	35,699	30,858
Expenses
Real estate depreciation and amortization	7,893	6,124
Loan impairment charge		12,000
Property-related	61	529
General and administrative	6,874	6,104
Acquisition expenses	2,040	65
Total operating expenses	16,868	24,822
Operating income	18,831	6,036
Other income (expense)
Interest and other expense	(15)	(16)
Interest expense	(8,140)	(9,458)
Net other expense	(8,155)	(9,474)
Income (loss) from continuing operations	10,676	(3,438)
Income from discontinued operations	148	625
Net income (loss)	10,824	(2,813)
Net loss attributable to non-controlling interests	(44)	(9)
Net income (loss) attributable to MPT common stockholders	$ 10,780	$ (2,822)
Earnings per common share - basic and diluted
Income (loss) from continuing operations attributable to MPT common stockholders	$ 0.09	$ (0.05)
Income from discontinued operations attributable to MPT common stockholders		0.01
Net income (loss) attributable to MPT common stockholders	$ 0.09	$ (0.04)
Weighted average shares outstanding
Basic	110,400	79,176
Diluted	110,408	79,176
Dividends declared per common share	$ 0.20	$ 0.20

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2011	Mar. 31, 2010
Operating activities
Net income (loss)	$ 10,824	$ (2,813)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization	8,084	7,038
Straight-line rent revenue	(1,735)	(1,851)
Share-based compensation	1,838	1,529
Increase in accounts payable and accrued liabilities	2,331	618
Decrease in interest and rent receivable	(801)	(3,090)
Loan impairment charge		12,000
Amortization of deferred financing costs and debt discount	986	1,477
Other adjustments	(2,241)	(3,838)
Net cash provided by operating activities	19,286	11,070
Investing activities
Real estate acquired	(173,486)
Principal received on loans receivable	580	5,247
Investment in loans receivable and other investments	(5,463)	(2,348)
Construction in progress and other	(4,647)	(1,448)
Net cash (used for) provided by investing activities	(183,016)	1,451
Financing activities
Revolving credit facilities, net	98,400	(12,000)
Payments of term debt	(6,945)	(285)
Distributions paid	(22,374)	(16,110)
Sale of common stock, net		9,555
Lease deposits and other obligations to tenants	3,612	2,179
Other financing activities	(361)	(369)
Net cash provided by (used for) financing activities	72,332	(17,030)
Decrease in cash and cash equivalents for period	(91,398)	(4,509)
Cash and cash equivalents at beginning of period	98,408	15,307
Cash and cash equivalents at end of period	7,010	10,798
Interest paid	5,261	3,862
Supplemental schedule of non-cash investing activities:
Assumption of mortgage loan (as part of real estate acquired)	(14,592)
Supplemental schedule of non-cash financing activities:
Distributions declared, unpaid	22,403	$ 16,325
Assumption of mortgage loan (as part of real estate acquired)	$ 14,592

Organization	3 Months Ended
Organization	Mar. 31, 2011
Organization [Abstract]
Organization	1. Organization Medical Properties Trust, Inc., a Maryland corporation, was formed on August 27, 2003 under the General Corporation Law of Maryland for the purpose of engaging in the business of investing in, owning, and leasing commercial real estate. Our operating partnership subsidiary, MPT Operating Partnership, L.P. (the “Operating Partnership”), through which we conduct all of our operations, was formed in September 2003. Through another wholly-owned subsidiary, Medical Properties Trust, LLC, we are the sole general partner of the Operating Partnership. At present, we directly own substantially all of the limited partnership interests in the Operating Partnership. We have operated as a real estate investment trust (“REIT”) since April 6, 2004, and accordingly, elected REIT status upon the filing in September 2005 of our calendar year 2004 federal income tax return. Accordingly, we will not be subject to U.S. federal income tax, provided that we continue to qualify as a REIT and our distributions to our stockholders equal or exceed our taxable income. Certain activities we undertake must be conducted by entities which we elected to be treated as taxable REIT subsidiaries (“TRS”). Our TRSs are subject to both federal and state income taxes. Our primary business strategy is to acquire and develop real estate and improvements, primarily for long-term lease to providers of healthcare services such as operators of general acute care hospitals, inpatient physical rehabilitation hospitals, long-term acute care hospitals, surgery centers, centers for treatment of specific conditions such as cardiac, pulmonary, cancer, and neurological hospitals, and other healthcare-oriented facilities. We manage our business as a single business segment.

Summary of Significant Accounting Policies	3 Months Ended
Summary of Significant Accounting Policies	Mar. 31, 2011
Summary of Significant Accounting Policies [Abstract]
Summary of Significant Accounting Policies	2. Summary of Significant Accounting Policies Unaudited Interim Condensed Consolidated Financial Statements: The accompanying unaudited interim condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States for interim financial information, including rules and regulations of the Securities and Exchange Commission. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the three month period ended March 31, 2011, are not necessarily indicative of the results that may be expected for the year ending December 31, 2011. The condensed consolidated balance sheet at December 31, 2010 has been derived from the audited financial statements at that date but does not include all of the information and footnotes required by accounting principles generally accepted in the United States for complete financial statements. For further information about significant accounting policies, refer to the consolidated financial statements and footnotes thereto included in the Annual Report on Form 10-K, as amended, for the year ended December 31, 2010.

Real Estate and Lending Activities

3 Months Ended

Mar. 31, 2011

Real Estate and Lending Activities [Abstract]

Real Estate and Lending Activities

3. Real Estate and Lending Activities

Acquisitions

On January 4, 2011, we acquired the real estate of the 19-bed, 4-year old Gilbert Hospital in a suburb of Phoenix, Arizona area for $17.1 million. Gilbert Hospital is operated by affiliates of Visionary Health, LLC, the same group that we expect will also operate the hospital that we are currently developing in Florence, Arizona. We acquired this asset subject to an existing lease that expires in May 2022.

On January 31, 2011, we acquired for $23.5 million the real estate of the 60-bed Atrium Medical Center at Corinth in the Dallas area, a long-term acute care hospital that was completed in 2009 and is subject to a lease that expires in June 2024. In addition, through one of our affiliates, we invested $1.3 million to acquire approximately 19% of a joint venture arrangement with an affiliate of Vibra Healthcare, LLC (“Vibra”) that will manage and has acquired a 51% interest in the operations of the facility. We also made a $5.2 million working capital loan to the joint venture. The former operators of the hospital, comprised primarily of local physicians, retained ownership of 49% of the operating entity.

On February 4, 2011, we purchased for $58 million the real estate of Bayonne Medical Center, a 6-story, 278-bed acute care hospital in the New Jersey area of metropolitan New York, and leased the facility to the operator under a 15-year lease, with six 5-year extension options. The operator is an affiliate of a private hospital operating company that acquired the hospital in 2008.

On February 9, 2011, we acquired the real estate of the 306-bed Alvarado Hospital in San Diego, California for $70 million from Prime Healthcare Services, Inc. (“Prime”). Prime is the operator of the facility and will lease the facility under a 10-year lease that provides, under certain conditions for lease extensions.

On February 14, 2011, we completed the acquisition of the Northland LTACH Hospital located in Kansas City, a 35-bed hospital that opened in April 2008 and has a lease that expires in 2028. This hospital was part of a three property acquisition announced in December 2010 and is currently being operated by RehabCare. The purchase price of this hospital was $19.5 million, which included the assumption of a $16 million existing mortgage loan that matures in January 2018.

We funded these acquisitions using cash on-hand and proceeds from our existing revolving credit facilities.

As part of these acquisitions, we purchased the following assets (dollar amounts in thousands):


Land	$	16,151
Building		157,834
Intangible lease assets — subject to amortization (weighted average useful life of 13.3 years)		14,093

Total	$	188,078

From the respective acquisition dates, these five acquired hospitals contributed $3.2 million of revenue and $2.0 million of income (excluding related acquisition expenses) for the three months ended March 31, 2011. In addition, we incurred $2.0 million of acquisition related costs in the 2011 first quarter, of which $1.6 million related to acquisitions consummated as of March 31, 2011. The purchase price allocations attributable to the identifiable assets acquired and liabilities assumed related to the acquisitions made during the quarter ended March 31, 2011 are preliminary as we are waiting on additional information to perform our final analysis. When all relevant information is obtained, resulting changes, if any, to our provisional purchase price allocations will be retrospectively adjusted to reflect new information obtained about the facts and circumstances that existed as of the respective acquisition dates that, if known, would have affected the measurement of the amounts recognized as of those dates.

The results of operations for each of the properties acquired are included in our consolidated results from the effective date of each acquisition. The following table sets forth certain unaudited pro forma consolidated financial data for 2011 and 2010, as if each significant acquisition in 2011 was consummated on the same terms at the beginning of 2010. Supplemental pro forma earnings were adjusted to exclude $1.6 million and $0.1 million of acquisition-related costs on consummated deals incurred in 2011 and 2010, respectively (dollar amounts in thousands except per share data).


	For the Three Months
	Ended March 31,
	2011		2010
Total revenues	$	37,757	$	37,480
Net income (loss) attributable to MPT common stockholders		13,871		(1,575	)
Net income (loss) per share attributable to MPT common stockholders-diluted	$	0.12	$	(0.02	)

Leasing Operations

In March 2010, we re-leased our Covington facility, located in Covington, Louisiana. The lease has a fixed term of 15 years with an option, at the lessee’s discretion, to extend the term for three additional periods of five years each. Under the terms of the lease, rent during 2010 was based on an annual rate of $1.4 million, and on January 1, 2011, rent began increasing annually by 2%. At the end of each term, the tenant has the right to purchase the facility at a price generally equivalent to the greater of our undepreciated cost and fair market value. Separately, we also obtained an interest in the operations of the tenant whereby we may receive additional consideration based on the profitability of such operations.

As of March 31, 2011, we have advanced approximately $28 million to the operator/lessee of Monroe Hospital in Bloomington, Indiana pursuant to a working capital loan agreement, with no additional advances in the first quarter of 2011. In addition, as of March 31, 2011, we have $12.5 million of rent, interest and other charges owed to us by the operator, of which $5.4 million of interest receivables are significantly more than 90 days past due. Because the operator has not made all payments required by the working capital loan agreement and the related real estate lease agreement, we consider the loan to be impaired. During the first quarter of 2010, we evaluated alternative strategies for the recovery of our advances and accruals and at that time determined that the future cash flows of the current tenant or related collateral would, more likely than not, result in less than a full recovery of our loan advances. Accordingly, we recorded a $12 million charge in the 2010 first quarter to recognize the estimated impairment of the working capital loan. During the third quarter of 2010, we determined that it was reasonably likely that the existing tenant would be unable to make certain lease payments that become due in future years. Accordingly, we recorded a valuation allowance for unbilled straight-line rent in the amount of $2.5 million. At March 31, 2011, our net investment (exclusive of the related real estate) of $28.7 million is our maximum exposure to Monroe and the amount is deemed collectible/recoverable. In making this determination, we considered our first priority secured interest in approximately (i) $4 million in hospital patient receivables, (ii) cash balances of approximately $4 million, and (iii) 100% of the membership interests of the operator/lessee and our assessment of the realizable value of our other collateral.

We continue to evaluate possible operating strategies for the Monroe hospital. We have entered into a forbearance agreement with the operator whereby we have generally agreed, under certain conditions, not to fully exercise our rights and remedies under the lease and loan agreements during limited periods. We have not committed to the adoption of a plan to transition ownership or management of the Monroe hospital to any new operator, and there is no assurance that any such plan will be completed. Moreover, there is no assurance that any plan that we ultimately pursue will not result in additional charges for further impairment of our working capital loan. We have not recognized any interest income on the Monroe loan since it was considered impaired in the 2010 first quarter.

For the three months ended March 31, 2011 and 2010, revenue from affiliates of Prime (including rent and interest from mortgage and working capital loans) accounted for 30.4% and 33.9%, respectively, of total revenue. For the three months ended March 31, 2011 and 2010, revenue from Vibra (including rent and interest from working capital loans) accounted for 12.5% and 14.2%, respectively, of total revenue.

Debt

3 Months Ended

Mar. 31, 2011

Debt [Abstract]

Debt

4. Debt

The following is a summary of debt (dollar amounts in thousands):


	As of March 31, 2011						As of December 31, 2010
	Balance			Interest Rate			Balance			Interest Rate
Revolving credit facilities	$	98,400		Variable			$	—		Variable
Senior unsecured notes — fixed rate through July and October 2011 due July and October 2016		125,000			7.333%-7.871	%		125,000			7.333%-7.871	%
Exchangeable senior notes:
Principal amount		91,175			6.125%-9.250	%		91,175			6.125%-9.250	%
Unamortized discount		(2,302	)					(2,585	)

Term loans:		88,873						88,590
Principal amount		165,331		Various				157,683		Various
Unamortized discount		(1,250	)					(1,303	)

		164,081						156,380

	$	476,354					$	369,970

As of March 31, 2011, principal payments due on our debt (which exclude the effects of any discounts recorded) are as follows (dollar amounts in thousands):


2011	$	19,627
2012		41,332
2013		141,749
2014		1,765
2015		1,783
Thereafter		273,650

Total	$	479,906

To fund the acquisitions disclosed in Note 3, we used cash on-hand, borrowed $98.4 million on our revolving credit facilities, and assumed a $16 million mortgage loan. This mortgage loan requires monthly principal and interest payments based on a 30-year amortization period. The mortgage loan has a fixed rate at 6.2%, matures on January 1, 2018 and can be prepaid after January 1, 2013, subject to a certain prepayment premium.

During the second quarter 2010, we entered into an interest rate swap to fix $65 million of our $125 million senior notes, starting July 31, 2011 (date on which the interest rate is scheduled to turn variable) through maturity date (or July 2016), at a rate of 5.507%. We also entered into an interest rate swap to fix $60 million of our senior notes starting October 31, 2011 (date on which the related interest rate is scheduled to turn variable) through the maturity date (or October 2016) at a rate of 5.675%. At March 31, 2011, the fair value of the interest rate swaps is $3.1 million, which is reflected in accounts payable and accrued expenses on the condensed consolidated balance sheet.

We account for our interest rate swaps as cash flow hedges. Accordingly, the effective portion of changes in the fair value of our swaps is recorded as a component of accumulated other comprehensive income/loss on the balance sheet until the underlying debt matures while the ineffective portion is recorded through earnings. We estimate the fair value of interest rate swaps using the market standard methodology of netting the discounted fixed cash payments and the discounted expected variable cash receipts. The variable cash receipts are based on an expectation of interest rates derived from observable market interest rate curves. In addition, credit valuation adjustments are incorporated in the fair values to account for potential nonperformance risk, both our own nonperformance risk and the respective counterparty’s nonperformance risk. We did not have any hedge ineffectiveness in the periods; therefore, there was no income statement effect recorded during the three month period ended March 31, 2011.

Our debt facilities impose certain restrictions on us, including restrictions on our ability to: incur debts; grant liens; provide guarantees in respect of obligations of any other entity; make redemptions and repurchases of our capital stock; prepay, redeem or repurchase debt; engage in mergers or consolidations; enter into affiliated transactions; dispose of real estate; and change our business. In addition, the agreements governing our debt facilities limit the amount of dividends we can pay to 90% of normalized adjusted funds from operations, as defined in the agreements, on a rolling four quarter basis starting for the fiscal quarter ending March 31, 2012 and thereafter. Prior to March 31, 2012, a similar dividend restriction exists but at a higher percentage for transitional purposes. These agreements also contain provisions for the mandatory prepayment of outstanding borrowings under these facilities from the proceeds received from the sale of properties that serve as collateral, except a portion may be reinvested subject to certain limitations, as defined in the credit facility agreement.

In addition to these restrictions, the new credit facility contains customary financial and operating covenants, including covenants relating to our total leverage ratio, fixed charge coverage ratio, mortgage secured leverage ratio, recourse mortgage secured leverage ratio, consolidated adjusted net worth, facility leverage ratio, and borrowing base interest coverage ratio. This facility also contains customary events of default, including among others, nonpayment of principal or interest, material inaccuracy of representations and failure to comply with our covenants. If an event of default occurs and is continuing under the facility, the entire outstanding balance may become immediately due and payable. At March 31, 2011, we were in compliance with all such financial and operating covenants.

Common Stock	3 Months Ended
Common Stock	Mar. 31, 2011
Common Stock [Abstract]
Common Stock	5. Common Stock During the first quarter of 2010, we sold 0.9 million shares of our common stock under our at-the-market equity offering program, at an average price of $10.77 per share, for total proceeds, net of a 2% sales commission, of $9.6 million.

Stock Awards	3 Months Ended
Stock Awards	Mar. 31, 2011
Stock Awards [Abstract]
Stock Awards	6. Stock Awards Our Second Amended and Restated Medical Properties Trust, Inc. 2004 Equity Incentive Plan (the “Equity Incentive Plan”) authorizes the issuance of common stock options, restricted stock, restricted stock units, deferred stock units, stock appreciation rights, performance units and awards of interests in our Operating Partnership. The Equity Incentive Plan is administered by the Compensation Committee of the Board of Directors. We have reserved 7,441,180 shares of common stock for awards under the Equity Incentive Plan for which 3,220,150 shares remain available for future stock awards as of March 31, 2011. We awarded 269,085 and 221,815 shares in the first quarter of 2011 and 2010, respectively, of time-based restricted stock to management, independent directors, and certain employees (2011 only). These awards vest quarterly based on service, over three years, in equal amounts. In addition, our management team and certain employees (2011 only) were awarded 229,938 and 182,600 performance based awards in the first quarter of 2011 and 2010, respectively. These awards vest ratably over a three year period based on the achievement of certain performance measures, with a carry-back and carryforward provision through December 31, 2014 (2010 awards) and December 31, 2015 (2011 awards). Dividends on these awards are paid only upon achievement of the performance measures.

Fair Value of Financial Instruments

3 Months Ended

Mar. 31, 2011

Fair Value of Financial Instruments [Abstract]

Fair Value of Financial Instruments

7. Fair Value of Financial Instruments

We have various assets and liabilities that are considered financial instruments. We estimate that the carrying value of cash and cash equivalents, and accounts payable and accrued expenses approximates their fair values. Included in our accounts payable and accrued expenses are our interest rate swaps, which are recorded at fair value. We estimate the fair value of our loans, interest, and other receivables by discounting the estimated future cash flows using the current rates at which similar receivables would be made to others with similar credit ratings and for the same remaining maturities. We determine the fair value of our exchangeable notes based on quotes from securities dealers and market makers. We estimate the fair value of our senior notes, revolving credit facilities, and term loans based on the present value of future payments, discounted at a rate which we consider appropriate for such debt.

The following table summarizes fair value information for our financial instruments: (amounts in thousands)


	March 31,						December 31,
	2011						2010
	Book			Fair			Book			Fair
Asset (Liability)	Value			Value			Value			Value
Interest and rent receivables	$	26,978		$	20,894		$	26,176		$	20,265
Loans		220,868			214,594			215,985			209,126
Debt, net		(476,354	)		(470,038	)		(369,970	)		(359,910	)

Discontinued Operations

3 Months Ended

Mar. 31, 2011

Discontinued Operations [Abstract]

Discontinued Operations

8. Discontinued Operations

In the fourth quarter 2010, we sold the real estate of our Montclair Hospital, an acute care medical center, to Prime for proceeds of $20.0 million. We realized a gain on the sale of $2.2 million.

In October 2010, we sold the real estate of our Sharpstown hospital in Houston, Texas to a third party for proceeds of $3.0 million resulting in a gain of $0.7 million.

In April 2010, we sold the real estate of our Centinela Hospital, a 369-bed acute care medical center located in Inglewood, California, to Prime for $75 million resulting in a gain of approximately $6 million.

The following table presents the results of discontinued operations, which includes the revenue and expenses of the previously-owned facilities noted above, for the three months ended March 2011 and 2010 (dollar amounts in thousands except per share amounts):


	For the Three Months
	Ended March 31,
	2011		2010
Revenues	$	—	$	2,515
Net income		148		625
Earnings per share — diluted	$	—	$	0.01

Earnings Per Share

3 Months Ended

Mar. 31, 2011

Earnings Per Share [Abstract]

Earnings Per Share

9. Earnings Per Share

Our earnings per share were calculated based on the following (amounts in thousands):


	For the Three Months
	Ended March 31,
	2011			2010
Numerator:
Income (loss) from continuing operations	$	10,676		$	(3,438	)
Non-controlling interests’ share in continuing operations		(44	)		(9	)
Participating securities’ share in earnings		(315	)		(351	)

Income from continuing operations, less participating securities share in earnings		10,317			(3,798	)

Income from discontinued operations attributable to MPT common stockholders		148			625

Net income (loss), less participating securities’ share in earnings	$	10,465		$	(3,173	)


Denominator:
Basic weighted-average common shares		110,400			79,176
Dilutive share options		8			—

Diluted weighted-average common shares		110,408			79,176

For the three months ended March 31, 2011 and 2010, 0.1 million of options were excluded from the diluted earnings per share calculation as they were not determined to be dilutive. Shares that may be issued in the future in accordance with our exchangeable senior notes were excluded from the diluted earnings per share calculation as they were not determined to be dilutive.

Contingencies	3 Months Ended
Contingencies	Mar. 31, 2011
Contingencies [Abstract]
Contingencies	10. Contingencies We are a party to various legal proceedings incidental to our business. In the opinion of management, after consultation with legal counsel, the ultimate liability, if any, with respect to those proceedings is not presently expected to materially affect our financial position, results of operations or cash flows.

Comprehensive Income

3 Months Ended

Mar. 31, 2011

Comprehensive Income [Abstract]

Comprehensive Income

11. Comprehensive Income (loss)

The following table provides a summary of comprehensive income (loss) for the applicable periods (in thousands):


	For the Three Months
	Ended March 31,
	2011			2010
Net income (loss)	$	10,824		$	(2,813	)
Other comprehensive income:
Unrealized gain on interest rate swaps		517			—

Total comprehensive income (loss)		11,341			(2,813	)
Comprehensive income attributable to non-controlling interests		(44	)		(9	)

Comprehensive income (loss) attributable to MPT common stockholders	$	11,297		$	(2,822	)

Subsequent Events	3 Months Ended
Subsequent Events	Mar. 31, 2011
Subsequent Events [Abstract]
Subsequent Events	12. Subsequent Events In April 2011, our operating partnership and a wholly-owned subsidiary of our operating partnership closed on a private offering of $450 million unsecured senior notes. These notes mature in 2021 and the interest rate is fixed at 6.875% per year. Contemporaneously with the closing of the notes, we repaid and terminated our $150 million term loan facility ($142.4 million of which was outstanding at March 31, 2011) and our $9 million collateralized term loan facility ($8.4 million outstanding of March 31, 2011). In connection with the notes offering, we amended our existing credit agreement, which now provides for a $330 million unsecured revolving credit facility that matures in October 2015. We paid down in full the revolving credit facility’s outstanding balance with the proceeds from the notes offering. We will use the remaining proceeds from the offering (approximately $210 million) for general business purposes, which may include investment opportunities and debt reduction. In connection with this refinancing, we expect to recognize an approximate $4 million charge in the second quarter primarily related to the write-off of previously deferred loan costs and discounts associated with the term loan facilities noted above.